Union Cabinet Approves Rs.330 Crore Loan To Help Three Psu Pharma Cos

The Union Cabinet Has Approved Loans Worth Rs.330.35 Crore For Three Public Sector Pharma Companies For Meeting The Employees’ Liabilities. The Three Psu Companies Are Indian Drugs & Pharmaceuticals Limited (Idpl), Rajasthan Drugs And Pharmaceuticals Ltd (Rdpl) And Hindustan Antibiotics Limited (Hal).Around Rs.158 Crore Will Be Utilised To Clear The Unpaid Salaries And Another Rs.172 Crore Will Go Towards Meeting Vrs Liability. Hal Will Get Rs.280.15 Crore, While Rdpl Will Get Rs.43.7 Crore And Idpl Rs.6.50 Crore. The Decision Would Mitigate Sufferings Of More Than 1,000 Employees Of These Psus, An Official Statement Said.Cabinet Also Approved The Constitution Of A Committee Of Ministers To Take All Decisions Pertaining To The Closure Or Strategic Sale Of Four Public Sector Undertakings, Including The Sale Of Assets And Clearance Of Outstanding Liabilities.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!